Status: Not yet recruiting
Safety and Efficacy of Roflumilast Foam 0.3% in Adolescent and Adult Subjects With Hidradenitis Suppurativa
This study investigates the efficacy of topical roflumilast foam in patients with HS.
Participants needed: 10
Trial details
Phase: Phase 2Age: 12+Biological sex: AllType: InterventionalSponsor: Harrison DermatologyUpdated: Jul 9, 2026Locations: 1
Eligibility criteria
Male or female subjects aged 12 years or older at time of consent (or assent). [+7]
Medical condition or physical examination abnormality that would prevent study p... [+16]